Kevin Kotler, 10% Owner at Recro Pharma, Inc. (REPH), bought 241,338 shares at $2.50 ($603K) on 2014-12-02, disclosed to the SEC on 2014-12-04.
Open-market purchase of $603k REPH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| BDSI | SELL | 2019-04-15 | $10.0M | — | Filing → |
| NVLN | SELL | 2018-12-27 | $483K | — | Filing → |
| REPH | SELL | 2017-12-22 | $750K | — | Filing → |